ID   VA-ES-BJ BAF47
AC   CVCL_QW58
SY   VA-ES-BJ_BAF47; VAESBJ_BAF47
DR   GEO; GSM2409700
DR   GEO; GSM2409701
DR   GEO; GSM2409702
DR   GEO; GSM2409703
DR   GEO; GSM2409704
DR   GEO; GSM2409705
DR   GEO; GSM2787359
DR   Wikidata; Q54992644
RX   PubMed=28945250;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 7773; NF2; Simple; p.Ser87Ter (c.260C>A); Zygosity=Homozygous (from parent cell line).
CC   Transfected with: HGNC; 11103; SMARCB1.
CC   Omics: H3K27ac ChIP-seq epigenome analysis.
CC   Omics: H3K27me3 ChIP-seq epigenome analysis.
CC   Omics: H3K4me3 ChIP-seq epigenome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1785 ! VA-ES-BJ
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
RX   PubMed=28945250; DOI=10.1038/ng.3958;
RA   Nakayama R.T., Pulice J.L., Valencia A.M., McBride M.J.,
RA   McKenzie Z.M., Gillespie M.A., Ku W.L., Teng M.-X., Cui K.-R.,
RA   Williams R.T., Cassel S.H., Qing H., Widmer C.J., Demetri G.D.,
RA   Irizarry R.A., Zhao K.-J., Ranish J.A., Kadoch C.;
RT   "SMARCB1 is required for widespread BAF complex-mediated activation of
RT   enhancers and bivalent promoters.";
RL   Nat. Genet. 49:1613-1623(2017).
//